Infusion-Related Reactions Subsequent to Avelumab, Durvalumab, and Atezolizumab Administration: A Retrospective Observational Study
Article in Clinics and Practice (February 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Characteristics and predictors of infusion-related reactions to rituximab in patients with B-cell non-Hodgkin lymphoma
Article in Journal of Chemotherapy (October 2023)
A novel prednisone premedication protocol significantly decreases infusion‑related reactions of rituximab in newly diagnosed diffuse large B‑cell lymphoma
Article in Oncology Letters (April 2023)